ライフサイエンスコーパス: immunization

1 ation of the study (25 weeks after the final immunization).

2 ted by future campaigns and catch-up routine immunization.

3 in mice at a reduced dose compared with i.m. immunization.

4 w elicited B cell responses evolve following immunization.

5 caused the most viral meningitis before mass immunization.

6 lymphoid organs in response to infection or immunization.

7 D4(+) T cell response throughout primary TBE immunization.

8 ts in expansion of autoreactive B cells upon immunization.

9 g are protected from nHSV following maternal immunization.

10 and to neogenesis of high endothelium after immunization.

11 foods, whilst replacing the need for animal immunization.

12 were challenged a few weeks after the first immunization.

13 ere followed for 12 months after the initial immunization.

14 tionally viewed as surrogates for successful immunization.

15 ute to parasite killing following sporozoite immunization.

16 vancement of vaccine candidates and maternal immunization.

17 significantly elevated in response to NP-CGG immunization.

18 inct lineages following natural infection or immunization.

19 immune response that was boosted by a second immunization.

20 MAIT cells only increased after the first Ad immunization.

21 reases in GC B cells and Ab production after immunization.

22 creased only by 5-10% in the 3.5 years after immunization.

23 tem-specific antibodies induced by the first immunization.

24 oral immunoreactivity pattern measured after immunization.

25 V six weeks or one year following the second immunization.

26 d highlights a rational strategy for mucosal immunization.

27 serum Ab concentrations elicited by primary immunization.

28 s of cCXCR5(+) T cell following yellow fever immunization.

29 major challenge for both active and passive immunization.

30 ng whole-cell pertussis vaccines for primary immunization.

31 endent and were more common after the second immunization.

32 (i.e. antigen-inexperienced) and that after immunization.

33 ulated Ab responses at steady-state and upon immunization.

34 an attractive alternative option for passive immunization.

35 responses increased rapidly after the first immunization.

36 oung adults (n = 15) following childhood VZV immunization.

37 being essential for optimal protection after immunization.

38 resolved alternative to study the quality of immunizations.

39 ibody and T cell responses in mice after two immunizations.

40 zation, most strongly in females after Ad5hr immunizations.

41 s, which were comparably potent after only 2 immunizations.

42 ted antibody responses to gut infections and immunization(1).

43 Despite memory formation, secondary immunization 4 wk after primary immunization did not inc

44 lled human malaria infection) 3 months after immunization, a timing chosen to potentially discriminat

45 Maternal immunization against group B streptococcus (GBS) could p

46 A follow-up study confirmed that immunization against only the AipA or Asp14 binding doma

47 We conclude that SIM regimes for immunization against respiratory pathogens warrant furth

48 ocytophilum to productively infect mice, and immunization against their binding domains elicits a pro

49 Adhesin domain immunization also elicited interferon gamma (IFN-gamma)-

50 TMDI (Transient Microbiota Depletion-boosted Immunization), an approach that leverages antibiotic tre

51 cells specific for the antigenic bait during immunization and 2) to minimize subsequent laborious hyb

52 intained above baseline levels 2 years after immunization and could be boosted with a second immuniza

53 In this study, we used camelid immunization and proteomics to identify a large repertoi

54 ovides an introductory overview of vaccines, immunization and related issues and thereby aims to info

55 Waning public support for childhood immunization and subsequent recent outbreaks of vaccine-

56 oderate increase in immunogenicity following immunization and the extensive and variable breadth of h

57 ction of immunogens as candidates for active immunization and vice versa.

58 V vaccine regimens combining mucosal priming immunizations and systemic protein boosting.

59 stem region was much lower after the second immunization, and this suppression was most likely due t

60 administration of influenza and pneumococcal immunizations, and prescription of long-term oxygen ther

61 Three immunizations appeared essential for the elicitation of

62 Most vaccines in the Expanded Program on Immunization are universal childhood vaccines (eg, measl

63 global immunization strategies, like degree immunization, are optimal in most cases; the exception i

64 esults support the effectiveness of targeted immunization as a general practice.

65 unization and could be boosted with a second immunization at 1 year.

66 pients are not up-to-date on age appropriate immunizations at the time of transplant and thereafter.

67 ately needed to overcome transplant-specific immunization barriers to improve immunization rates in t

68 Gene- and immunization-based approaches to protect against Hla dur

69 ere stochastic strategies, like acquaintance immunization, begin to outstrip them in minimizing outbr

70 Immunization between 9 and 14 years of age should be enc

71 icators- anaemia, stunting and no/incomplete immunization by inter-linking maternal characteristics a

72 92.5% of children had completed the primary immunizations by their first birthday and 87.9% had rece

73 , to project costs for routine immunization, immunization campaigns, surveillance and laboratory reso

74 and can hinder the implementation of global immunization campaigns.

75 Postexposure immunization can prevent disease and reduce transmission

76 These data reveal that peripheral immunizations can generate brain T(RM) cells and will gu

77 en used in RV144 have indicated that booster immunizations can increase serum anti-Env antibody titer

78 ignificant risk of polio re-emergence should immunization cease.

79 nonvaccination decreased over time among the immunization cohort but remained stable among risk group

80 ccination to HepA among risk groups and the "immunization cohort" (those born in or after 2004).

81 r hepatitis C, and 22.6% and 25.9% among the immunization cohort.

82 In contrast, subcutaneous (s.c.) immunization conferred no protection against the p.v. ch

83 We propose that maternal immunization could provide protection against HSV for bo

84 Prophylactic approaches, such as maternal immunization, could prevent neonatal HSV (nHSV) infectio

85 e-cell pertussis (wP) vaccine in the primary immunization course in October 2004.

86 Improved immunization coverage with high-quality surveillance is

87 Experimental in vivo immunization data show that the ensilicated material can

88 n, secondary immunization 4 wk after primary immunization did not increase NP-specific IgG.

89 The blunting effect of pertussis immunization during pregnancy on infant antibody respons

90 n-polysaccharide neoglycogonjugates increase immunization efficacy by targeting and activating dendri

91 Despite national immunization efforts, including universal childhood hepa

92 challenge sera from these mice revealed that immunization elicited antibodies against AipA and Asp14

93 d CD4(+) T cell response prior to Env trimer immunization elicits neutralizing antibody development a

94 e [PCV13] as part of the Expanded Program on Immunization [EPI]), healthy children 5 to 10 years old

95 ter in life afforded by natural C. difficile immunization events require further investigation.

96 Rabbit immunization experiments identify key immunodominant sit

97 epta, and DT-Octa) that were used in in vivo immunization experiments in mice.

98 als will be useful as a benchmark for future immunization experiments.

99 This alternative method of immunization exploits the intrinsic adjuvancy of the att

100 bodies geometric mean titer ratios (post/pre-immunization) following a high dose were 2.6 (D30) and 2

101 Immunization for EAU with a retinal self-antigen caused

102 n vaccines are due using transplant-specific immunization guidelines.

103 imitations of this study are unknown routine immunization history and poor retention of vaccination c

104 ilable sources, to project costs for routine immunization, immunization campaigns, surveillance and l

105 taTeq vaccine into its Expanded Programme on Immunization in May 2012.

106 SPy_2191 immunization in mice generates bactericidal antibodies r

107 and cellular immune responses after a single immunization in older adults.

108 revented latency following active or passive immunization in preclinical studies.

109 will require passive protection via maternal immunization in pregnancy.

110 ivalent influenza inactivated vaccine (IIV3) immunization in pregnant women, and association with pro

111 rozoite protein (PfCSP), plateaued after two immunizations in a clinical trial of the radiation-atten

112 s a transplant community, we must prioritize immunizations in both pre and posttransplant care.

113 Somatic hypermutation after immunization indicates that engineered cells have the ca

114 saRNA LNP immunizations induce a Th1-biased response in mice, and

115 Moreover, intravenous immunization induced a high frequency of antigen-respons

116 Second immunization induced a plasmablast response to the highl

117 intradermal or aerosol delivery, intravenous immunization induced substantially more antigen-responsi

118 Both p.o. and s.c. immunizations induced Chlamydia-specific serum IgA.

119 TANCE Childhood varicella-zoster virus (VZV) immunization induces immune memory responses that protec

120 After two immunizations, IO-NP presentation and the TCHE tag indep

121 Immunization is a cornerstone of public health policy an

122 This study supports the idea that maternal immunization is a viable strategy for the prevention of

123 Intradermal (ID) immunization is an attractive route of vaccination becau

124 Annual influenza immunization is recommended for people with chronic obst

125 one of our proposed variants of acquaintance immunization leverages a logistically-realistic ongoing

126 in CD8(+) T cell responses to dendritic cell immunization, Listeria infection, and viral infection.

127 can prevent severe RSV illness, and maternal immunization may reduce illness in young infants.

128 mbryos, thus mimicking natural, pathological immunization mechanisms.

129 and significantly changed over the course of immunization, most strongly in females after Ad5hr immun

130 Immunization of Balb/c mice with different combinations

131 Immunization of C57BL/6J mice using these particles elic

132 However, immunization of chickens with rAPMV-3 expressing HA prot

133 Our results showed that immunization of chickens with rAPMV-3 or rNDV expressing

134 esent study show that a single intramuscular immunization of domestic pigs with OURT88/3 or BeninDelt

135 After a single intramuscular immunization of domestic pigs with the OURT88/3 isolate

136 Furthermore, immunization of HLA-DR transgenic mice with a mixture of

137 Immunization of HLA-DR transgenic mice with a mixture of

138 panel of MMP10-selective antibodies through immunization of llamas, a member of the camelid family,

139 Following immunization of mice and guinea pigs with INO-4800 we me

140 Immunization of mice by subcutaneous injection or epicut

141 ic B cell hybridomas was generated following immunization of mice with COBRA P1 and the corresponding

142 Immunization of mice with IgE-immune complexes induced g

143 We show in this study that immunization of mice with live typhoidal serovar, Salmon

144 l autoimmune encephalopathy (EAE) induced by immunization of mice with myelin oligodendrocyte glycopr

145 Subcutaneous immunization of mice with PM plus alum inhibits in vivo

146 Immunization of mice with the conjugate induced robust a

147 Immunization of mice with VSV-eGFP-SARS-CoV-2 elicits hi

148 Following immunization of mice, this immunogen strategy generated

149 sponse was observed following needle-free ID immunization of pigs.

150 Immunization of rabbits with bivalent Ebola VLPs produce

151 ty level of 60% obtained through homogeneous immunization of the population.

152 l spacers to achieve a more rapid and robust immunization of the population.

153 Here we show that a single-dose immunization of ZIKV purified inactivated vaccine (ZPIV)

154 tial immunization protocol, wherein each new immunization optimally increases the pressure on the imm

155 on of IgG-SCs presented in the spleen during immunization or after recall revealed similarities but a

156 Moreover, p.o. immunization or infection with Chlamydia confers protect

157 However, we found that NS1 immunization or passive transfer of NS1 antibodies faile

158 uggest that increasing the number of booster immunizations or delivering additional viral antigens ma

159 ns of gliadin in complete Freund's adjuvant (immunization) or of soluble gliadin or ovalbumin (ear ch

160 ing and how they are interconnected with the immunization phase through a third phase of the CRISPR-C

161 Protection starts with an immunization phase, in which short pieces of the invader

162 After prime and boost immunization, pigs were challenged with H1N1pdm09 virus.

163 The immunization potential of OVA-biotin-filariae was compar

164 tion is not available, Advisory Committee on Immunization Practices (ACIP) criteria are used to guide

165 ccination according to Advisory Committee on Immunization Practices (ACIP) guidelines.

166 n consortium ABIRISK (Anti-Biopharmaceutical Immunization: prediction and analysis of clinical releva

167 , Bexsero) into its publicly funded national immunization program at a reduced two-dose priming sched

168 evalence against which the impact of the HPV immunization program can be measured in the future.

169 baseline against which the impact of the HPV immunization program in Brazil can be measured in future

170 ne (Rotavac) was introduced in the universal immunization program in India in 2016.

171 ted the early impact of the school-based HPV immunization program on cervical dysplasia in women in B

172 RV1 in the Kenyan immunization program provides significant protection aga

173 of the historical strength of the country's immunization program.

174 The standard schedule of national immunization programs for infants may not be sufficient

175 Countries must strengthen immunization programs to achieve high vaccination covera

176 This has implications for immunization programs, vaccine development, and tubercul

177 have introduced rotavirus vaccine into their immunization programs.

178 Single immunization protects mice against infection with the hi

179 by this rationale, we set out to develop an immunization protocol aimed at maximizing the induction

180 imize bnAb evolution is through a sequential immunization protocol, wherein each new immunization opt

181 ruses have proven protective following short immunization protocols in which pigs were challenged a f

182 Following short immunization protocols, naturally attenuated African swi

183 Maternal DeltagD-2 immunization provided significant protection and reduced

184 is work shows that V1V2 scaffold DNA priming immunization provides a method to focus immune responses

185 nt-specific immunization barriers to improve immunization rates in this high-risk population.

186 ecent Strategic Advisory Group of Experts on Immunization recommendation and World Health Organizatio

187 , the Strategic Advisory Group of Experts on Immunization, recommended the 1-drop strategy as a dose-

188 nd posttransplant periods; making a complete immunization record universally available and easily acc

189 conducting interviews, reviewing medical and immunization records, identifying exposed persons, and p

190 Health Organization's Expanded Programme on Immunization reduce antibiotic consumption substantially

191 on in anti-ovalbumin IgE in plasma following immunization, reduced numbers of tolerogenic dendritic c

192 d through patient and provider interview and immunization registries.

193 cords from provincial cervical screening and immunization registries.

194 e was monitored with the use of the Citywide Immunization Registry.

195 ere asthma exacerbation in the 4 weeks after immunization, requiring a short course of systemic corti

196 emia [low IgA], splenomegaly, and diminished immunization responses).

197 In mice, high dose immunization results in minimal local reactogenicity, is

198 LmCen(-/-) immunization results in protection and an immune respons

199 ess the immunogenicity of the new bOPV + IPV immunization schedule and gains in type 2 immunity with

200 lowing PCV13 introduction into the Cambodian immunization schedule, there have been declines in VT pn

201 always sensitive to changes in the preceding immunization scheme.

202 ur knowledge, method to assay the quality of immunization schemes for mice: shortly after a recall wi

203 ongly correlated with the different employed immunization schemes.

204 Neutralization titers in pre- and post-immunization sera from 133 adults immunized with one of

205 After the second immunization, serum neutralizing activity was detected i

206 Rapid scale-up and strengthening of routine immunization services to reach children and to deliver m

207 ure than MSs, including provision of routine immunization services.

208 Whether typhoid immunization should be prioritized in periurban and rura

209 SPy_2191 immunization significantly reduces streptococcal load in

210 ), and simultaneous systemic and respiratory immunization (SIM) by both routes in Babraham pigs, usin

211 s to produce IL-10, TGF-beta, or both at the immunization site, which might account for increased num

212 +)CD8(+) T cells as compared to subcutaneous immunization (SNP-SC).

213 Despite annual immunization, solid organ transplant (SOT) patients rema

214 Parenteral immunization, specifically subcutaneous and intramuscula

215 e evasion tactics blunt the effectiveness of immunization strategies and are impeding progress to con

216 across their populations, and how to target immunization strategies appropriately.

217 However, standard immunization strategies are insufficient with increasing

218 In this paper, we investigate how different immunization strategies perform under realistic conditio

219 We also discuss two different immunization strategies that have the potential to confe

220 cine supply for the potential global demand, immunization strategies to optimize the effectiveness an

221 Our results suggest that global immunization strategies, like degree immunization, are o

222 cutaneous microenvironment to enable diverse immunization strategies.

223 aking and regulatory decisions regarding RSV immunization strategy and monitor the impact of future v

224 ntiretroviral therapy as well as preclinical immunization studies that provide a clear rationale for

225 Ultimately, therapeutic immunization targeting the subset of variants resistant

226 sponse to primary and secondary yellow fever immunization - the model for acute infection in humans -

227 Our data indicate that during pulmonary immunization, the GM-CSF released by AECs orchestrates t

228 were isolated at different time points after immunization, their VH and VL genes were sequenced, and

229 s were parameterised to have a herd-immunity immunization threshold of around 90% coverage, and under

230 phs had reduced Ab responses after NP-Ficoll immunization; thus, BAFF produced by both cDCs and Nphs

231 Pre-immunization titers against H3 HA-pseudoviruses containi

232 g a highly controlled system of administered immunizations to inbred mice.

233 ndividuals is possible, provided that proper immunization tools are used.

234 e populations are often compromised, passive immunization treatments using broadly neutralizing antib

235 We studied the impact of maternal immunization using a whole-cell GBS vaccine on the durat

236 rate the protective effect of mucosal rectal immunization using an attenuated ZIKV strain.

237 Compared to other vaccine formulations, immunization using CoPoP liposomes admixed with recombin

238 za treatments are acutely needed and passive immunizations using broadly neutralizing anti-influenza

239 Plasmablast response after the first immunization was exclusively directed to the conserved H

240 hese mechanisms in flavivirus infections and immunizations, we studied recall responses to envelope p

241 In prime:boost guinea pig immunizations, when formulated with the MF59-like adjuva

242 g lymph nodes (dLN) as early as 6-18 h after immunization, which were predominantly proinflammatory i

243 f LXA(4) in lymph nodes draining the site of immunization, while at the same time amplifying LXA(4) i

244 oung IghPax5/+ mice at steady state and upon immunization, while their number moderately declined in

245 Immunization with 4CMenB, ascertained from the national

246 ng either the gene encoding LMP2 and LMP7 by immunization with a cardiac TnI peptide.

247 Inducing EAE by immunization with a myelin oligodendrocyte glycoprotein

248 We previously showed that maternal immunization with a replication-defective HSV vaccine ca

249 of virus-specific effector CD8(+) T cells or immunization with a vaccine that induces virus-specific

250 e have demonstrated that respiratory mucosal immunization with a viral-vectored vaccine imprints AwM,

251 However, immunization with AMA1 bound with RON2L (AMA1-RON2L) ind

252 A single immunization with an adenovirus serotype 26 vector-based

253 or expressing RSV antigen to boost a primary immunization with an attenuated RSV warrants further eva

254 study, we evaluated the efficacy of maternal immunization with an experimental trivalent (gC2, gD2, a

255 In contrast, immunization with an inactivated virus vaccine, even whe

256 Immunization with an inactive TcdB fragment prevents C.

257 eukocidin (PVL), we evaluated whether active immunization with attenuated forms of Hla (HlaH35L/H48L)

258 lasmodium vivax infections as well as during immunization with candidate malaria vaccines are summari

259 ID immunization with cdAMP/Nano-11 expanded the population

260 In A. nancymaae, intradermal (i.d.) immunization with chimera plus single-mutant heat-labile

261 In this study, we demonstrated that immunization with CspZ-YA, a CspZ mutant protein with no

262 Pre-exposure to uninfected sand fly bites or immunization with defined sand fly salivary proteins was

263 were designed to compare active and passive immunization with DeltagD-2 versus an adjuvanted gD subu

264 nt study tested the hypothesis that maternal immunization with DeltagD-2 would protect neonates.

265 We showed previously that intranasal immunization with dsc(19)CfaE, a soluble variant of the

266 Primary immunization with European TBE vaccines, as recommended

267 stance to acute infection can be restored by immunization with highly attenuated vaccines.IMPORTANCE

268 d to improve global coverage through routine immunization with inactivated polio vaccine (IPV), to en

269 However, whether infection or immunization with one serovar provides protection agains

270 In both of these murine strains, immunization with our modified protocols resulted in a s

271 x vivo alterations were not detectable after immunization with PfSPZ Vaccine, TCR Vdelta2, and mucosa

272 develop abnormally elevated IgE responses to immunization with potential allergens.

273 Two days after intranasal immunization with PS-GAMP-adjuvanted H1N1 vaccine, stron

274 MAbs were obtained by immunization with PSA and characterized by competition s

275 Immunization with recombinant ALVAC/gp120 alum vaccine p

276 munization with RSV was boosted by secondary immunization with RSV or with a chimeric recombinant bov

277 ated a prime-boost strategy in which primary immunization with RSV was boosted by secondary immunizat

278 We demonstrated that a single immunization with SARS-CoV-2 mRNA, but not with the reco

279 While immunization with single trimers from elite neutralizati

280 itidis (SEn) by a single amino-acid residue, immunization with STmOmpD confers minimal protection to

281 lso observed in human CD141+ DCs 1 day after immunization with the adenovirus-based vaccines.

282 asures against JUNV infection are limited to immunization with the Candid#1 vaccine and immune plasma

283 Childhood immunization with the live-attenuated varicella-zoster v

284 The Th17 response to immunization with the MINCLE-dependent adjuvant trehalos

285 cific IgE and IgG1 production in response to immunization with the model allergen papain.

286 Furthermore, immunization with the NTS S.

287 rs of influenza-specific BMPCs 4 weeks after immunization with the seasonal inactivated influenza vac

288 Here we report, immunization with the trimeric porin OmpD from Salmonell

289 model of nHSV, we demonstrated that maternal immunization with the trivalent vaccine protected offspr

290 Immunization with these antigens yielded 100-1,000 IgG s

291 Through immunization with these peptide epitopes, we have succes

292 Furthermore, murine immunization with this peptide elicited IgG responses th

293 Immunization with this strain led to a response that inc

294 Immunization with this surrogate, especially when couple

295 et in RV144 developed only after the priming immunization with V1V2 DNA.

296 meric scaffold immunogen followed by booster immunizations with a combination of DNA and protein in r

297 ovine casein, mice received four, monthly IN immunizations with nanoemulsion formulated with casein.

298 KO) mice mounted normal humoral responses to immunizations with T-dependent and T-independent (Type 1

299 ffector immune cells into the lungs, in situ immunization without the need for exogenous antigens, in

300 ntrol, a vaccine that requires only a single immunization would be optimal.